Dalibor Hodko's profile

Dalibor Hodko

CEO

Nexogen, Inc.

I'm working on

3 years ago

Rapid Point-of-Care Platforms for Multiplexed Diagnostics

About

Nexogen NexiDx™ POC platform: (i) multiple sample-to-answer assays on the same cartridge, 25 min, RNA/DNA, protein) 200 targets; (ii) electric/magnetic field accelerated amplification reactions, 4 min; (ii) unique adaptable microfluidics platform. D.Hodko >40 publ.s; 22 issued patents, >30 grants

Partnering listings

Learn more

Nexogen, Inc.

Low-cost PON platform for rapid micronutrient deficiency detection

Nexogen's NexiDx™ offers a low-cost PON platform for rapid detection of micronutrient deficiencies. Using advanced microfluidics and magnetic bead-based sample prep, it delivers accurate results in 20-25 minutes, suitabl...

TechnologyIn developmentCompany

Dalibor Hodko

CEO

Nexogen, Inc.

Work experience

Nexogen, Inc.

CEO

Top industry applications

Not enough data yet.
Results may appear later and can be imperfect.

Open to opportunities in

Not enough data yet.
Results may appear later and can be imperfect.

Last updated Nov 2023